Showing results (1-10 of 151) with videos related to
Sort By:
Pageof 16
Cancers|July 29, 2025
Molecular Pathways and Targeted Therapies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)Jonathan Weiss, Shannon A Carty, Yasmin H KarimiLeukemia & Lymphoma|June 9, 2025
Cost effectiveness of mosunetuzumab and CAR-T cell therapy in relapsed/refractory follicular lymphomaMeng-Hsuan Lin, Jonathan Weiss, Tycel J Phillips, et al.Hematology. American Society of Hematology. Education Program|December 10, 2021
Immunology 101: fundamental immunology for the practicing hematologistShannon A CartyFrontiers in Oncology|October 16, 2023
Biological insights into the role of TET2 in T cell lymphomasShannon A CartyBritish Journal of Haematology|January 21, 2025
Origins of T-cell-mediated autoimmunity in acquired aplastic anaemiaAura Enache, Shannon A Carty, Daria V BabushokCritical Reviews in Immunology|August 5, 2020
DNA Methylation in T-Cell Development and DifferentiationLuis O Correa, Martha S Jordan, Shannon A CartyPlos One|September 11, 2014
Interleukin-4 regulates eomesodermin in CD8+ T cell development and differentiationShannon A Carty, Gary A Koretzky, Martha S JordanClinical Lymphoma, Myeloma & Leukemia|May 4, 2023
SOHO State of the Art Updates and Next Questions | New Pathways and New Targets in PTCL: Staying on TargetShannon A Carty, Carlos A Murga-Zamalloa, Ryan A WilcoxBlood Advances|April 4, 2023
Adding venetoclax to lenalidomide and rituximab is safe and effective in patients with untreated mantle cell lymphomaTycel J Phillips, David Bond, Radihka Takiar, et al.Cutis|March 19, 2005
A review of clinical experience and recommendations for improving patient careJonathan WeissPageof 16